Ex parte NOONE et al. - Page 7




          Appeal No. 1995-1703                                                        
          Application 07/897,304                                                      


          (main answer, page 8).                                                      
               The examiner’s explanation is unclear as to whether the                
          rejection is based on an alleged failure to comply with the                 
          written description requirement or the enablement requirement               
          of 35 U.S.C. § 112, first paragraph, or both.  The written                  
          description and enablement requirements are, of course,                     
          separate and distinct.  Vas-Cath, Inc. v. Mahurkar, 935 F.2d                
          1555, 1563, 19 USPQ2d 1111, 1117 (Fed. Cir. 1991).  For the                 
          sake of completeness, we shall evaluate the rejection in light              
          of both requirements.                                                       


               Before doing so, however, we find it necessary to make                 
          two observations about the claim language in question.  First,              
          the examiner’s interpretation that the claims (via independent              
          claims 1, 15 and 21) require a thermoplastic having an                      
          elongation value of at least 150% at temperatures below about               
          -20EC is not well taken.  The claim limitations in question,                
          read on their face or in light of the underlying disclosure,                
          simply do not support such an interpretation.  For example,                 
          page 7 in the specification discusses the elongation value                  
          without any mention of temperature.  Second, it is evident                  
                                          7                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007